Listing 1 - 5 of 5 |
Sort by
|
Choose an application
oncology --- urological oncological diseases --- cancer biomarkers --- cancer therapy --- molecular tumor pathology --- tumor microenvironment --- Oncology --- Carcinogenesis --- Oncology. --- Cancer --- Oncogenesis --- Pathogenesis of cancer --- Tumorigenesis --- Pathology --- Genetic toxicology --- Molecular carcinogenesis --- Pathology, Molecular --- Tumors --- Molecular aspects --- Molecular aspects. --- Pathogenesis
Choose an application
Convertases are widely expressed activating enzymes involved in various physiological and pathological processes. The purpose of this book is to provide detailed and updated information on the role of these molecules in cancer. This book is the first to summarize current knowledge about the importance of protein precursors maturation by the convertases in tumor progression, angiogenesis and metastasis. In each chapter, the importance of the convertases in the activation of various cancer-related molecules including growth factors, adhesion molecules and proteases is discussed. Also this book covers the role of some convertases in the clinical setting. The book will be of interest to basic researchers as well as clinicians. It will also interest those working in the cancer research area and the pharmaceutical industry, who are looking for new strategies in cancer therapy. Finally, this book is also a useful reference for researchers and clinicians pursuing research on growth factors, adhesion molecules, proteases and their implications in the processes of tumor progression, angiogenesis and metastasis.
Cancer --- Enzyme inhibitors --- Carcinogenesis --- Treatment. --- Therapeutic use. --- Molecular aspects. --- Genetic aspects. --- Oncogenesis --- Pathogenesis of cancer --- Tumorigenesis --- Pathology --- Genetic toxicology --- Molecular carcinogenesis --- Pathology, Molecular --- Antagonists, Enzyme --- Enzyme antagonists --- Enzymes --- Inhibitors, Enzyme --- Metabolic inhibitors --- Chemical inhibitors --- Cancer therapy --- Cancer treatment --- Pathogenesis --- Antagonists --- Inhibitors --- Therapy --- Oncology. --- Oncology . --- Chemistry. --- Cancer Research. --- Chemistry/Food Science, general. --- Physical sciences --- Tumors --- Cancer research. --- Cancer research
Choose an application
Cancer --- Neoplasms, Experimental. --- Neoplasms --- Neoplasms. --- Medical Oncology. --- Treatment --- Research --- therapy. --- Research. --- Treatment. --- Clinical Oncology --- Oncology, Medical --- Oncology, Clinical --- Benign Neoplasms --- Malignancy --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Neoplasias --- Neoplasm, Benign --- Tumor --- Experimental Neoplasms --- Experimental Neoplasm --- Neoplasm, Experimental --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors --- Therapy --- Malignant Neoplasms --- Malignant Neoplasm --- Neoplasm, Malignant --- Neoplasms, Malignant --- Medical Oncology --- cancer biology --- molecular carcinogenesis --- genetics and genomics --- stem cells --- developmental biology --- oncology
Choose an application
Tumors can be induced by a variety of physical and chemical carcinogens. The resulting tumor cells are usually abnormal in their morphology and behavior and transmit their abnormalities to their daughter tumor cells. Most theories of the pathogenesis of tumors suggest that carcinogens in some way cause alterations either of the genomes or of inheritable patterns of gene expression in normal cells, which then cause morphological and behavioral changes. This volume presents a collection of articles aimed at the question by what genetic or epigenetic mechanisms carcinogens can cause morphological abnormalities of tumor cells. It includes reviews of cellular targets of known carcinogens, and presents varying viewpoints of how morphological abnormalities and the actions of carcinogens might be related. The volume will be of interest to all those who are involved in cancer research or in the prevention, diagnosis or management of tumors in humans or animals.
Cancer. --- Cancer cells. --- Carcinogenesis. --- Carcinogenesis - Molecular aspects. --- Carcinogens. --- Gene Expression Regulation, Neoplastic. --- Genomic Instability. --- Neoplasms. --- Carcinogenesis --- Cancer cells --- Cancer --- Gene Expression Regulation, Neoplastic --- Genomic Instability --- Carcinogens --- Genetics --- Neoplasms --- Gene Expression Regulation --- Diseases --- Noxae --- Biology --- Pathologic Processes --- Genetic Phenomena --- Mutation --- Genetic Processes --- Pathological Conditions, Signs and Symptoms --- Genetic Variation --- Phenomena and Processes --- Biological Science Disciplines --- Toxic Actions --- Chemical Actions and Uses --- Natural Science Disciplines --- Chemicals and Drugs --- Disciplines and Occupations --- Oncology --- Medicine --- Health & Biological Sciences --- Molecular aspects --- Pathophysiology --- Genetic aspects --- Molecular aspects. --- Pathophysiology. --- Genetic aspects. --- Cancer genetics --- Molecular carcinogenesis --- Medicine. --- Cancer research. --- Biomedicine. --- Cancer Research. --- Biomedicine general. --- Cancer genes --- Cells --- Pathology, Cellular --- Pathology, Molecular --- Oncology. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Tumors --- Health Workforce --- Biomedicine, general. --- Cancer research --- Cancer Biology. --- Biomedical Research. --- Research. --- Biological research --- Biomedical research --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors
Choose an application
The scientific community has made significant progress in our molecular understanding of sporadic and hereditary colorectal carcinogenesis and progression. Thie pertains to, e.g., the discovery of (mutated) oncogenes and tumor suppressor genes, microsatellite instabilities, modifications in DNA repair, cellular aging, signaling cascades, genomic, epigenetic, transcriptional, translational, and protein modifications, as well as microbiotic factors and further parameters. Progression and metastasis have been more intensively studied, especially during recent years, leading to an intensified knowledge on molecular protagonists and microenvironmental interactions contributing to invasion, dissemination, and metastasis; still, more concerted efforts need to be made to better understand issues such as metastasis to different sites or the metastatic heterogeneity of single cells. Nevertheless, based on actual discoveries, personalized medicine, together with highly interdisciplinary therapeutic strategies combining advanced levels of surgical techniques, oncology, and radiation in neoadjuvant, adjuvant, or palliative settings, has started to improve the clinical prognosis of individual patients with colorectal cancer. The present Special Issue features articles of excellent international experts with the latest data in the fields mentioned. With this Special Issue, we aim to deepen discussions amongst colleagues in all kinds of disciplines working on this disease and to intensify interdisciplinary collaborations aimed at an ultimate understanding of strategies to defeat and prevent, colorectal cancer, and its progression.
Phage --- bacteriophages --- diet --- infection --- colorectal --- cancer --- nutrition --- circulating tumor cells --- colorectal cancer --- EPISPOT assay --- CellSearch® system --- predictive value --- chromatin density --- nanoscale --- tumour cell heterogeneity --- microRNAs --- metastasis --- super-resolution microscopy --- early onset --- cohort --- epidemiology --- liquid biopsy --- biomarker --- indirect carcinogenesis --- bovine meat and milk factors (BMMF) --- chronic zoonosis --- multiplex --- tumor immunology --- immune landscape --- spontaneous feline intestinal tumors --- comparative oncology --- tumor budding --- CTNNB1 --- genome-wide methylation array --- methylation --- miRNA --- colon cancer --- personalized treatment --- drug combinations --- Matrix Metalloproteinases (MMPs) --- polyp --- TIMPs --- MMP polymorphisms --- MMP targeting --- S100A4 --- DKK1 --- Wnt signaling --- patient survival --- gender --- rectal cancer --- radiochemotherapy --- radiosensitivity --- DNA double-strand breaks --- deposited energy --- quality of life --- blood values --- (molecular) carcinogenesis --- cancer progression --- (single) cancer cell heterogeneity --- models --- infectious agents --- (targeted) therapy --- personalized medicine
Listing 1 - 5 of 5 |
Sort by
|